dapsone has been researched along with Black Death in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " On theoretical grounds we provide computed evidence why dapsone is not a pharmacodynamic lead for drug profiling because enthalpic terms do not change significantly at the moment of ligand binding to target." | 1.56 | Dapsone is not a Pharmacodynamic Lead Compound for its Aryl Derivatives. ( Abdallah, HH; Laufer, S; Salvador-Atonal, K; Scior, T, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Scior, T | 1 |
| Abdallah, HH | 1 |
| Salvador-Atonal, K | 1 |
| Laufer, S | 1 |
1 other study available for dapsone and Black Death
| Article | Year |
|---|---|
Dapsone is not a Pharmacodynamic Lead Compound for its Aryl Derivatives.
Topics: Anti-Bacterial Agents; Dapsone; Dihydropteroate Synthase; Drug Design; Drug Discovery; Humans; Ligan | 2020 |